Revidia Therapeutics, Inc.
Pioneering drug therapies to reverse heart damage
LAMOINE, United States · Founded 2017 · $2.9M raised
- Headquarters
- LAMOINE, Maine
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- revidiatherapeutics.com
- Total Funding
- $2.9M
About
Revidia Therapeutics is a Lamoine, Maine clinical-stage biopharmaceutical company developing small molecule drugs that activate the body's innate regenerative mechanisms to reverse cardiac damage. Their lead candidate MSI-1436 inhibits PTP1B to stimulate heart muscle regeneration, with the initial indication targeting cardiomyopathy in Duchenne muscular dystrophy patients.
Summary
Revidia Therapeutics, Inc. is a Biotech company based in LAMOINE, United States, founded in 2017. It has raised $2.9M in total.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/revidia-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/revidia-therapeutics-inc" alt="Revidia Therapeutics, Inc. on Indexed.vc" width="260" height="76" /></a>